Details for Patent: 11,807,629

Which drugs does patent 11,807,629 protect, and when does it expire?

Patent 11,807,629 protects XPOVIO and is included in one NDA.

This patent has thirty-one patent family members in eighteen countries.

Drugs Protected by US Patent 11,807,629

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Karyopharm Theraps	XPOVIO	selinexor	TABLET;ORAL	212306-001	Jul 3, 2019		RX	Yes	No			Y	Y
Karyopharm Theraps	XPOVIO	selinexor	TABLET;ORAL	212306-002	Apr 15, 2021		RX	Yes	No			Y	Y
Karyopharm Theraps	XPOVIO	selinexor	TABLET;ORAL	212306-003	Apr 15, 2021		RX	Yes	No			Y	Y
Karyopharm Theraps	XPOVIO	selinexor	TABLET;ORAL	212306-004	Apr 15, 2021		RX	Yes	Yes			Y	Y

International Family Members for US Patent 11,807,629

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2015301484
Australia	2020203246
Australia	2021286266
Canada	2957266
China	107072992
China	111481553
China	111484483